poLight ASA Receives Follow-on Purchase Order from Top Tier Consumer OEM for TWedge® Wobulator Technical Samples Advancing AR|MR Design

Tønsberg, Norway 5 November 2025 - poLight ASA (OSE: PLT) today announced that
the company has received a follow-on purchase order worth approximately NOK
900,000 for TWedge® wobulator technical samples supporting a top tier consumer
OEM to advance their AR|MR product design efforts.

"Our ongoing customer interactions regarding wobulation technology are
providing valuable insights as we shape this promising new product," said Dr.
Øyvind Isaksen, CEO of poLight ASA. "Our TWedge® wobulator technology
leverages the same advanced tunable optics platform as our TLens® product,
which is widely used in autofocus imaging systems. This follow-on purchase
order marks another important milestone, reflecting growing interest and
confidence from our customers. We are confident that both TLens® and TWedge®
wobulator technologies will help solve key AR|MR design challenges and deliver
superior user experiences."

The delivery of TWedge® technical samples is expected to be completed in Q4
2025.

For further information, please contact:
Dr Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98

About poLight ASA
poLight ASA (listed on the Oslo Stock Exchange: PLT) offers a patented,
proprietary tunable optics technology, starting with its first product, TLens®
which replicates "the human eye" experience in autofocus cameras used in
devices such as smartphones, wearables, barcode scanners, machine vision
systems and various medical equipment. poLight's TLens® enables better system
performance and new user experiences due to benefits such as extremely fast
focus, small footprint, no magnetic interference, low power consumption and
constant field of view. poLight is based in Tønsberg, Norway, with employees
in Finland, France, UK, US, China, Taiwan, Japan, and the Philippines. For
more information, please visit https://www.polight.com
(https://www.polight.com/)

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication at
2025-11-05 12:01 CET.